BIOLOGICAL RESPONSE MODIFIERS IN MELANOMA

被引：12

作者：

BRIDGEWATER, JA

GORE, ME

机构：

[1] Department of Medicine, Royal Marsden Hospital, London

来源：

BRITISH MEDICAL BULLETIN | 1995年 / 51卷 / 03期

关键词：

D O I：

10.1093/oxfordjournals.bmb.a072985

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：656 / 677

页数：22

共 94 条

[1]

AAPRO MS, 1993, EUR J CANCER A, V28, P613

[2] LYSIS OF AUTOLOGOUS MELANOMA-CELLS BY TUMOR-INFILTRATING LYMPHOCYTES - ASSOCIATION WITH CLINICAL-RESPONSE [J].

AEBERSOLD, P ;

HYATT, C ;

JOHNSON, S ;

HINES, K ;

KORCAK, L ;

SANDERS, M ;

LOTZE, M ;

TOPALIAN, S ;

YANG, J ;

ROSENBERG, SA .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (13) :932-937

[3] MELANOMA-CELLS AND NORMAL MELANOCYTES SHARE ANTIGENS RECOGNIZED BY HLA-A2-RESTRICTED CYTOTOXIC T-CELL CLONES FROM MELANOMA PATIENTS [J].

ANICHINI, A ;

MACCALLI, C ;

MORTARINI, R ;

SALVI, S ;

MAZZOCCHI, A ;

SQUARCINA, P ;

HERLYN, M ;

PARMIANI, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :989-998

[4] EXPANSION OF PERIPHERAL-BLOOD NATURAL-KILLER-CELLS CORRELATES WITH CLINICAL OUTCOME IN CANCER-PATIENTS RECEIVING RECOMBINANT SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA(2) [J].

ATZPODIEN, J ;

KIRCHNER, H ;

KORFER, A ;

HADAM, M ;

SCHOMBURG, A ;

MENZEL, T ;

DECKERT, M ;

FRANZKE, A ;

VOLKENANDT, M ;

DALLMANN, I ;

GROSSE, J ;

POLIWODA, H .

TUMOR BIOLOGY, 1993, 14 (06) :354-359

[5]

ATZPODIEN J, 1991, EUR J CANCER S, V4, pS88

[6] MULTICENTER RANDOMIZED TRIAL OF DACARBAZINE ALONE OR IN COMBINATION WITH 2 DIFFERENT DOSES AND SCHEDULES OF INTERFERON ALFA-2A IN THE TREATMENT OF ADVANCED MELANOMA [J].

BAJETTA, E ;

DILEO, A ;

ZAMPINO, MG ;

SERTOLI, MR ;

COMELLA, G ;

BARDUAGNI, M ;

GIANNOTTI, B ;

QUEIROLO, P ;

TRIBBIA, G ;

BERNENGO, MG ;

MENICHETTI, ET ;

PALMERI, S ;

RUSSO, A ;

CRISTOFOLINI, M ;

ERBAZZI, A ;

FOWST, C ;

CRISCUOLO, D ;

BUFALINO, R ;

ZILEMBO, N ;

CASCINELLI, N .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :806-811

[7] TREATMENT WITH HIGH-DOSE MOUSE MONOCLONAL (ANTI-GD3) ANTIBODY-R24 IN PATIENTS WITH METASTATIC MELANOMA [J].

BAJORIN, DF ;

CHAPMAN, PB ;

WONG, GY ;

CODY, BV ;

CORDONCARDO, C ;

DANTES, L ;

TEMPLETON, MA ;

SCHEINBERG, D ;

OETTGEN, HF ;

HOUGHTON, AN .

MELANOMA RESEARCH, 1992, 2 (5-6) :355-362

[8] METASTATIC MALIGNANT-MELANOMA TREATED WITH COMBINED BOLUS AND CONTINUOUS INFUSION INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS [J].

BAR, MH ;

SZNOL, M ;

ATKINS, MB ;

CIOBANU, N ;

MICETICH, KC ;

BOLDT, DH ;

MARGOLIN, KA ;

ARONSON, FR ;

RAYNER, AA ;

HAWKINS, MJ ;

MIER, JW ;

PAIETTA, E ;

FISHER, RI ;

WEISS, GR ;

DOROSHOW, JH .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) :1138-1147

[9] IMMUNOGENIC VARIANTS OBTAINED BY MUTAGENESIS OF MOUSE MASTOCYTOMA P815 .2. LYMPHOCYTE-T-MEDIATED CYTOLYSIS [J].

BOON, T ;

VANSNICK, J ;

VANPEL, A ;

UYTTENHOVE, C ;

MARCHAND, M .

JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (05) :1184-1193

[10] THE TYROSINASE GENE CODES FOR AN ANTIGEN RECOGNIZED BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS [J].

BRICHARD, V ;

VANPEL, A ;

WOLFEL, T ;

WOLFEL, C ;

DEPLAEN, E ;

LETHE, B ;

COULIE, P ;

BOON, T .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :489-495

← 1 2 3 4 5 6 7 8 9 10 →